METATONS: Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy

Sponsor
University of Aarhus (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05445856
Collaborator
(none)
130
2
22

Study Details

Study Description

Brief Summary

A randomized controlled trial evaluating the efficacy and safety of single-shot intraoperative methadone for postoperative pain in patients undergoing tonsillectomy. Fentanyl is used as an active comparator

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

This study is an investigator-initiated, prospective, randomised controlled trial with two arms: an intervention arm (methadone) and a control arm (fentanyl). Patients scheduled for tonsillectomy at Randers Regional Hospital, Denmark, will be approached for study participation.

Patients are randomised in a 1:1 ratio in blocks of varying sizes (between 4 and 8) to receive either intraoperative methadone or fentanyl. The randomisation assignment will be handled by the hospital pharmacy using a web-based central randomisation procedure (www.sealedenvelope.com).

The study drug will be prepared by the hospital pharmacy at Aarhus University Hospital and delivered as kits with identical appearance, marked with the randomization number (1-130). On the day of surgery, a kit will be opened and a 10 ml syringe with study drug (methadone 2 mg/ml or fentanyl 30 microgram/ml or ) will prepared by a health care professional (nurse or medical doctor not involved in the study or the treatment of patients). Once prepared, the blinded study drug will be given to and handled by one of the research team members and administered after induction of anesthesia and prior to surgery

The dose of the study drug will be administered as intravenous bolus dose in equipotent doses (0.2 mg/kg / 3 μg/kg) corresponding to 1 ml for every 10 kg of ideal body weight (women: height (cm) - 105. Men: height (cm) - 100)) after induction of anaesthesia and before the start of surgery.

Postoperative data will be obtained by reviewing hospital records, by interview and electronic questionnaires sent by email.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
130 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy - a Randomized Controlled Trial
Anticipated Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Methadone

Single-shot intravenous methadone 0.2 mg/kg administered intraoperatively

Drug: Methadone
Methadone is administered as a single intravenous dose after induction of anesthesia and prior to initiation of surgery

Active Comparator: Fentanyl

Single-shot intravenous fentanyl 3 microgram/kg administered intraoperatively

Drug: Fentanyl
Fentanyl is administered as a single intravenous dose after induction of anesthesia and prior to initiation of surgery

Outcome Measures

Primary Outcome Measures

  1. Postoperative pain [On arrival at the post-anesthesia care unit]

    Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)

  2. Opioid consumption [First 5 postoperative days]

    Cumulative postoperative opioid consumption in morphine equivalents

Secondary Outcome Measures

  1. Postoperative pain [1, 2, 3, 5 and 7 days after surgery]

    Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)

  2. Opioid consumption [1 and 7 days after surgery]

    Cumulative postoperative opioid consumption in morphine equivalents

  3. Postoperative nausea and vomiting (none, mild, moderate, severe) [1, 2 and 3 days after surgery]

    Nausea and/or vomiting (PONV), proportion of patients with none or mild PONV

  4. Sedation [4 hours after surgery]

    Level of sedation (Ramsay Scale (1-4)), proportion of patients being co-operative, oriented and tranquil

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All patients (≥15 years) scheduled for elective tonsillectomy
Exclusion Criteria:
  • American Society of Anaesthesiologists (ASA) physical status IV or V

  • Allergy to study drugs

  • Daily use of opioids 7 days prior to surgery

  • Inability to provide informed consent

  • Severe respiratory insufficiency

  • Heart failure

  • Acute alcohol intoxication/delirium tremens

  • Increased intracranial pressure

  • Acute liver disease

  • Liver insufficiency

  • Kidney insufficiency

  • Treatment with rifampicin

  • Treatment with any drug prolonging the QT-interval

  • Pregnancy (every female not using contraceptives will be screened with urine human choriogonadotropin)

  • Breastfeeding

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Aarhus

Investigators

  • Study Chair: Lone Nikolajsen, PhD, DMSc, Aarhus University Hospital, Department of Anesthesia and Intensive Care

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT05445856
Other Study ID Numbers:
  • 2022-002496-11
First Posted:
Jul 6, 2022
Last Update Posted:
Aug 3, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Aarhus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022